| pubmed-article:3137036 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0041466 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0030771 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0041044 | lld:lifeskim |
| pubmed-article:3137036 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:3137036 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3137036 | pubmed:dateCreated | 1988-10-13 | lld:pubmed |
| pubmed-article:3137036 | pubmed:abstractText | Pefloxacin, which has been shown to have a high in vitro activity against Salmonella spp., was compared to cotrimoxazole in the treatment of typhoid fever in adults. In a prospective, randomized trial, 42 patients with bacteriologically documented typhoid fever received either 400 mg pefloxacin b.i.d. or 160/800 mg cotrimoxazole b.i.d. Duration of treatment was 14 days in both groups. All patients were cured without experiencing a relapse or becoming a salmonella carrier. Apyrexia and resolution of digestive and neurological symptoms were obtained in a significantly shorter time with pefloxacin than with cotrimoxazole. Pefloxacin was well tolerated and more effective than cotrimoxazole in the treatment of typhoid fever. | lld:pubmed |
| pubmed-article:3137036 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3137036 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3137036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3137036 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3137036 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:3137036 | pubmed:issn | 0934-9723 | lld:pubmed |
| pubmed-article:3137036 | pubmed:author | pubmed-author:HimmichHH | lld:pubmed |
| pubmed-article:3137036 | pubmed:author | pubmed-author:HajjiMM | lld:pubmed |
| pubmed-article:3137036 | pubmed:author | pubmed-author:BenbachirMM | lld:pubmed |
| pubmed-article:3137036 | pubmed:author | pubmed-author:el FilaliK... | lld:pubmed |
| pubmed-article:3137036 | pubmed:author | pubmed-author:el MdaghriNN | lld:pubmed |
| pubmed-article:3137036 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3137036 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:3137036 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3137036 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3137036 | pubmed:pagination | 361-3 | lld:pubmed |
| pubmed-article:3137036 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:meshHeading | pubmed-meshheading:3137036-... | lld:pubmed |
| pubmed-article:3137036 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3137036 | pubmed:articleTitle | Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults. | lld:pubmed |
| pubmed-article:3137036 | pubmed:affiliation | Infectious Diseases Unit, University Hospital, Casablanca, Morocco. | lld:pubmed |
| pubmed-article:3137036 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3137036 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:3137036 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3137036 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3137036 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3137036 | lld:pubmed |
